Literature DB >> 16275353

UBP43, an ISG15-specific deconjugating enzyme: expression, purification, and enzymatic assays.

Keun Il Kim1, Dong-Er Zhang.   

Abstract

UBP43 is the only deconjugating enzyme for the protein ISGylation system thus far identified. UBP43 activity is not critical for precursor processing, as UBP43-deficent cells can generate ISG15 conjugates upon type I interferon treatment. However, UBP43 deficiency caused a defect in the negative regulation of type I interferon signaling, resulting in enhanced and prolonged activation of Jak/Stat upon type I interferon treatment. This chapter describes the expression, purification, and enzymatic assays for UBP43.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275353     DOI: 10.1016/S0076-6879(05)98040-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  13 in total

1.  Two independent mechanisms promote expression of an N-terminal truncated USP18 isoform with higher DeISGylation activity in the nucleus.

Authors:  Christoph Burkart; Jun-Bao Fan; Dong-Er Zhang
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

Review 2.  Emerging roles for immunomodulatory functions of free ISG15.

Authors:  Jessica A Campbell; Deborah J Lenschow
Journal:  J Interferon Cytokine Res       Date:  2013-09-06       Impact factor: 2.607

3.  Diversity of ubiquitin and ISG15 specificity among nairoviruses' viral ovarian tumor domain proteases.

Authors:  Glenn C Capodagli; Michelle K Deaton; Erica A Baker; Ryan J Lumpkin; Scott D Pegan
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

4.  Ubp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signaling.

Authors:  Ming Yan; Jiann-Kae Luo; Kenneth J Ritchie; Ikuya Sakai; Kasuto Takeuchi; Ruibao Ren; Dong-Er Zhang
Journal:  Blood       Date:  2007-03-20       Impact factor: 22.113

5.  The mitochondrial pathway and reactive oxygen species are critical contributors to interferon-α/β-mediated apoptosis in Ubp43-deficient hematopoietic cells.

Authors:  Hwa Young Yim; Young Yang; Jong-Seok Lim; Myeong Seok Lee; Dong-Er Zhang; Keun Il Kim
Journal:  Biochem Biophys Res Commun       Date:  2012-06-05       Impact factor: 3.575

6.  UBE1L causes lung cancer growth suppression by targeting cyclin D1.

Authors:  Qing Feng; David Sekula; Yongli Guo; Xi Liu; Candice C Black; Fabrizio Galimberti; Sumit J Shah; Lorenzo F Sempere; Vincent Memoli; Jesper B Andersen; Bret A Hassel; Konstantin Dragnev; Ethan Dmitrovsky
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

7.  Enhanced protein expression in the baculovirus/insect cell system using engineered SUMO fusions.

Authors:  Li Liu; Joshua Spurrier; Tauseef R Butt; James E Strickler
Journal:  Protein Expr Purif       Date:  2008-08-05       Impact factor: 1.650

8.  Antiviral Properties of ISG15.

Authors:  Deborah J Lenschow
Journal:  Viruses       Date:  2010-09-28       Impact factor: 5.818

9.  Acetylation and activation of STAT3 mediated by nuclear translocation of CD44.

Authors:  Jia-Lin Lee; Mei-Jung Wang; Jeou-Yuan Chen
Journal:  J Cell Biol       Date:  2009-06-08       Impact factor: 10.539

10.  High yield expression of catalytically active USP18 (UBP43) using a Trigger Factor fusion system.

Authors:  Anja Basters; Lars Ketscher; Elke Deuerling; Christoph Arkona; Jörg Rademann; Klaus-Peter Knobeloch; Günter Fritz
Journal:  BMC Biotechnol       Date:  2012-08-23       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.